Page last updated: 2024-10-29

ketanserin and ARC

ketanserin has been researched along with ARC in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benekareddy, M1
Goodfellow, NM1
Lambe, EK1
Vaidya, VA1

Other Studies

1 other study available for ketanserin and ARC

ArticleYear
Enhanced function of prefrontal serotonin 5-HT(2) receptors in a rat model of psychiatric vulnerability.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010, Sep-08, Volume: 30, Issue:36

    Topics: AIDS-Related Complex; Amphetamines; Analysis of Variance; Animals; Animals, Newborn; Behavior, Anima

2010